MedTrace Logo

Epidural Neostigmine for Labor Pain

NCT00779467 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-09-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see which dose of epidural neostigmine is the best additive to use with the numbing medication used in an epidural during labor.

Conditions

  • Labor Pain

Interventions

DRUG

Neostigmine

utilizing 3 different dosages of neostigmine and comparing it to the standard of fentanyl. Infusion runs via PCA throughout labor analgesia.

DRUG

Bupivacaine

DRUG

fentanyl

fentanyl 2 mcg/ml

Sponsors & Collaborators

  • Wake Forest University

    lead OTHER

Principal Investigators

  • Peter H Pan, MD · Wake Forest University Health Sciences OB Anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-11-30
Completion
2013-11-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00779467 on ClinicalTrials.gov